← Browse by Condition
Medical Condition

non hodgkin lymphoma b cell

Total Trials
1
Recruiting Now
1
Trial Phases
EARLY_Phase 1
NCT06446128 EARLY_Phase 1
Recruiting

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Enrollment
20 pts
Location
China
Sponsor
Shanghai Cell Therapy Group Co...
View Trial →